Cutaneous T-Cell Lymphoma
A rare lymphoma of T-cells that mainly affects the skin
Quick Facts
- Type: Cancer (non-Hodgkin lymphoma of the skin)
- Cells involved: T-cell white blood cells
- Most common form: Mycosis fungoides
- Course: Often slow-growing over many years
Overview
Cutaneous T-cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma, a cancer that starts in white blood cells called T-cells. Unlike most lymphomas, which begin in lymph nodes, CTCL primarily affects the skin. The most common form is called mycosis fungoides, and a more advanced, blood-involving form is called Sezary syndrome.
CTCL often develops slowly over many years and in its early stages can closely resemble common skin conditions such as eczema or psoriasis, which can delay diagnosis. For many people, particularly those diagnosed at an early stage, CTCL behaves as a chronic condition that is managed over the long term rather than rapidly progressing. Treatment can control the disease and relieve symptoms, and the outlook is often favorable in early-stage disease.
Symptoms
The symptoms of CTCL mainly affect the skin and can change in appearance over time.
- Flat, scaly, reddish patches, often on areas not usually exposed to the sun
- Raised, thicker plaques of skin
- Persistent itching, which can be severe
- Tumors or nodules on the skin in more advanced disease
- Widespread redness and scaling of much of the skin (erythroderma)
- Hair loss in affected areas
In advanced disease, lymph nodes may enlarge, and Sezary syndrome involves abnormal cells in the blood along with widespread skin redness and intense itching.
Causes
The exact cause of CTCL is not known. It develops when T-cells, a type of immune cell, undergo genetic changes that make them grow and behave abnormally and accumulate in the skin.
- Abnormal T-cells: the cancerous cells settle in the skin and cause the characteristic patches and plaques.
- Acquired gene changes: mutations build up over time in the affected cells, though the reasons are not fully understood.
CTCL is not contagious and is not passed from person to person. It is not caused by poor hygiene or by anything a person did, and most people have no clear risk factor.
Risk Factors
- Older age, as CTCL is more common in middle-aged and older adults
- Male sex, with a somewhat higher rate in men
- The condition is rare, and most people have no identifiable risk factor
Diagnosis
Diagnosing CTCL can be challenging because early skin changes look like common skin diseases. Several tests are usually needed.
- Skin biopsy: a sample of affected skin examined under a microscope, sometimes repeated over time, is the key test.
- Specialized tissue studies: tests that look at the proteins and gene patterns of the cells to confirm a T-cell lymphoma.
- Blood tests: check for abnormal T-cells in the blood, important for Sezary syndrome.
- Imaging: CT or PET scans to assess lymph nodes and internal organs in advanced disease.
Treatment
Treatment depends on the stage and how much of the skin and body is involved. Early-stage disease is often treated with skin-directed therapies, while advanced disease may need treatments that work throughout the body. Care is guided by specialists in skin lymphoma.
- Skin-directed treatments: topical corticosteroids, other topical medications, and light therapy (phototherapy) for patches and plaques.
- Radiation therapy: targeted radiation for localized lesions, or total skin radiation for widespread skin disease.
- Systemic therapies: medications that work throughout the body, including certain biologic and targeted treatments, for more advanced disease.
- Chemotherapy: used for advanced or aggressive disease.
- Supportive care: treatments to relieve itching and care for the skin.
Because CTCL is often a long-term condition, treatment focuses on controlling the disease and maintaining quality of life.
Prevention
There is no known way to prevent CTCL, since its cause is not understood and there are no clear avoidable risk factors. Care focuses on early recognition and ongoing management.
- See a doctor for any persistent, unexplained skin patches or plaques that do not respond to usual treatment
- Keep regular follow-up appointments once diagnosed to monitor for changes
- Care for the skin and treat itching to maintain comfort and quality of life
- Report new skin lesions, swelling of lymph nodes, or worsening symptoms promptly
When to See a Doctor
See a doctor or dermatologist for skin patches, plaques, or persistent itching that do not improve with standard treatments for eczema or psoriasis, especially if they last for months or keep changing. Seek prompt care if you notice:
- New skin tumors, nodules, or rapidly changing lesions
- Widespread skin redness and scaling
- Swollen lymph nodes, unexplained weight loss, or night sweats
- Signs of skin infection such as increasing pain, warmth, or fever
Frequently Asked Questions
What is cutaneous T-cell lymphoma?
It is a rare cancer that begins in immune cells called T-cells and mainly affects the skin, causing patches, plaques, itching, and sometimes tumors. The most common form is mycosis fungoides. It is a type of non-Hodgkin lymphoma.
Why is CTCL often mistaken for eczema or psoriasis?
In its early stages, CTCL causes scaly, itchy patches and plaques that look very similar to common skin conditions like eczema and psoriasis. Because it grows slowly, diagnosis can take time and often requires one or more skin biopsies to confirm.
Is cutaneous T-cell lymphoma curable?
Many people, especially those diagnosed at an early stage, can have their disease well controlled for years and live normal lives. It often behaves as a chronic condition managed with skin-directed and other treatments. Advanced disease is harder to treat but can still be managed.
Is CTCL contagious or inherited?
No. CTCL is not contagious and cannot be passed to other people. It is not known to be directly inherited, and most people who develop it have no family history or clear risk factor.
How is CTCL diagnosed?
A skin biopsy examined under a microscope is the main test, sometimes repeated over time, along with specialized studies of the cells. Blood tests and imaging help determine how much of the body is involved and guide treatment.
References
- National Cancer Institute (NCI). Mycosis Fungoides and Other Cutaneous T-Cell Lymphomas Treatment.
- MedlinePlus, U.S. National Library of Medicine. Cutaneous T-cell lymphoma.
- Leukemia & Lymphoma Society. Cutaneous T-Cell Lymphoma.
- National Organization for Rare Disorders (NORD). Cutaneous T-Cell Lymphoma.